Sources

• Familial Renal Cancer: Molecular Genetics and Surgical Management. Barrisford GW, Singer EA, Rosner IL, Linehan WM, Bratslavsky G. Int J Surg Oncol. 2011;2011:658767. Epub 2011 Aug 22.

• Birt-Hogg-Dubé syndrome with a renal angiomyolipoma: further evidence of a relationship between Birt-Hogg-Dubé syndrome and tuberous sclerosis complex. Byrne M, Mallipeddi R, Pichert G, Whittaker S. Australas J Dermatol. 2012 May;53(2):151-4. Epub 2011 Mar 10.

• A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. Capitanio U, Cloutier V, Zini L, Isbarn H, Jeldres C, Shariat SF, Perrotte P, Antebi E, Patard JJ, Montorsi F, Karakiewicz PI. BJU Int. 2009 Jun;103(11):1496-500. Epub 2008 Dec 8.

• Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. Houweling AC, Gijezen LM, Jonker MA, van Doorn MB, Oldenburg RA, van Spaendonck-Zwarts KY, Leter EM, van Os TA, van Grieken NC, Jaspars EH, de Jong MM, Bongers EM, Johannesma PC, Postmus PE, van Moorselaar RJ, van Waesberghe JH, Starink TM, van Steensel MA, Gille JJ, Menko FH. Br J Cancer. 2011 Dec 6;105(12):1912-9.

• Birt-Hogg-Dubé Syndrome: Clinical and Genetic Studies of 20 Families. Leter EM, Koopmans AK, Gille JJ, van Os TA, Vittoz GG, David EF, Jaspars EH, Postmus PE, van Moorselaar RJ, Craanen ME, Starink TM, Menko FH. J Invest Dermatol. 2008 Jan;128(1):45-9. Epub 2007 Jul 5.

• Hereditary kidney cancer: unique opportunity for disease-based therapy. Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R. Cancer. 2009 May 15;115(10 Suppl):2252-61.

• Birt-Hogg-Dubé syndrome: diagnosis and management. Menko FH, van Steensel MA, Giraud S, Friis-Hansen L, Richard S, Ungari S, Nordenskjöld M, Hansen TV, Solly J, Maher ER; European BHD Consortium. Lancet Oncol. 2009 Dec; 10(12):1199-206.

• FLCN gene-mutated renal cell neoplasms: mother and daughter cases with a novel germline mutation. Nagashima Y, Furuya M, Gotohda H, Takagi S, Hes O, Michal M, Grossmann P, Tanaka R, Nakatani Y, Kuroda N. Int J Urol. 2012 May;19(5):468-70. Epub 2011 Dec 29.

• Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Guillé F, Chopin DK, Mulders PF, Wood CG, Swanson DA, Figlin RA, Belldegrun AS, Pantuck AJ. J Clin Oncol. 2005 Apr 20;23(12):2763-71.

• Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. Pavlovich CP, Grubb RL, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM. J Urol. 2005;173:1482–6.

• Renal tumors in the Birt-Hogg-Dubé syndrome. Pavlovich CP, Walther MM, Eyler RA, Hewitt SM, Zbar B, Linehan WM, Merino MJ. Am J Surg Pathol. 2002 Dec;26(12):1542-52.

• Renal Tumor Biopsies for Evaluation of Small Renal Tumors: Why, in Whom, and How? Remzi M, Marberger M. Eur Urol. 2009 Feb;55(2):359-67. Epub 2008 Oct 7. Review.

• Incidental radiological finding of a renal tumour leading to the diagnosis of Birt-Hogg-Dubé syndrome. Schreuer M, Lemmerling M, Pauwels W, Dewilde D, Heyse C, Verstraete KL. JBR-BTR. 2011 Jan-Feb; 94(1):29-31.

• State of the Art of Disease – Specific Registries in Europe: Successes and Challenges. Tanner, SM. In: Rare2011 European Day Proceedings, 4 November 2011.

• Birt-Hogg-Dubé syndrome with renal angiomyolipoma. Tobino K, Seyama K. Intern Med. 2012;51(10):1279-80. Epub 2012 May 15.

• BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé Syndrome: A new series of 50 families and a review of published reports. Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM. J Med Genet. 2008 Jun;45(6):321-31.

• Birt-Hogg-Dubé Syndrome. Toro JR. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2006 Feb 27 [updated 2008 Sep 9].

• BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM. J Med Genet. 2008; 45: 321–31.

• Chromophobe renal cell carcinoma: A review of an uncommon entity. Vera-Badillo FE, Conde E, Duran I. Int J Urol. 2012 Jun 21.

• Guidelines on the management of renal cyst disease. Whelan, TF. Can Urol Assoc J. 2010 April; 4(2): 98–99.

• Cancer Research UK
  • Kidney cancer symptoms
• European Association of Urology guidelines
  • Renal cell carcinoma
• Macmillan Cancer Support
  • Kidney cancer: causes
  • Kidney cancer: staging and grading
  • Kidney cancer: symptoms
• National Cancer Institute
  • Dictionary
    • Histopathology
    • Neoplasm
    • Transitional cell cancer
    • What you need to know about
      • Kidney cancer: symptoms
      • Kidney cancer: diagnosis
      • What is Cancer?
• National Kidney and Urologic Diseases Information Clearinghouse
  • Simple kidney cysts.
• NHS Choices
  • Biopsy
  • Kidney cancer symptoms
• Patient.co.uk
  • Kidney cancer

Publication date: September 2012
Review date: September 2014